Abiopharma

🔍 GOTTSCHALK MARLA C (Executive)

Company: UL Solutions Inc. (ULS)

Report Date: 2026-06-08

Detailed Transactions and Holdings:

• Acquired 7 shares of Deferred Restricted Stock Units (Derivative)
  Date: 2026-06-08 | Code: A | equity_swap_involved: false | shares_owned_after: 4,969.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4
• Acquired 4 shares of Deferred Restricted Stock Units (Derivative)
  Date: 2026-06-08 | Code: A | equity_swap_involved: false | shares_owned_after: 2,809.00 | transaction_form_type: 4 | Footnotes: F1, F2, F5, F5, F4
• Acquired 3 shares of Deferred Restricted Stock Units (Derivative)
  Date: 2026-06-08 | Code: A | equity_swap_involved: false | shares_owned_after: 2,209.00 | transaction_form_type: 4 | Footnotes: F1, F2, F6, F6, F4

Footnotes:

• F1: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• F2: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
• F3: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
• F4: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
• F5: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
• F6: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.